COVID-19 treatment hope sparks US stocks rally

US stocks open the week like they closed last week: on a high note, amid news the US Food and Drug Administration (FDA) had authorized the use of a COVID-19 treatment.

About 30 minutes into the Monday trading session, the benchmark Dow Jones Industrial Average climbed 0.5 percent to 28,081.45.

The broad-based S&P 500 jumped 0.7% to 3,419.92, and the tech-rich Nasdaq Composite Index increased 0.8% to 11,400.51, remaining buoyant after more than 30 record closes in 2020.

The quiet days of late August often produce big swings in share prices, but Wall Street got a boost after the FDA on Sunday issued an “emergency use authorization” allowing doctors to administer plasma from people who have recovered from COVID-19 to treat new patients.

“Based on scientific evidence available, the FDA concluded this product may be effective in treating COVID-19 and that the known and potential benefits of the product outweigh the known and potential risks of the product in hospitalized COVID-19 patients,” the agency said in a statement.

AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.